
---
title: '热景生物新冠抗体检测试剂在印度获批上市'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7733'
author: 证券时报网
comments: false
date: Mon, 19 Jul 2021 13:07:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7733'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS688068" style="color: #2f67d1;text-decoration: none;" code="688068" target="_blank">热景生物</a>官微消息，近日，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SS688068" style="color: #2f67d1;text-decoration: none;" code="688068" target="_blank">热景生物</a>新冠抗体检测试剂获印度药品和医疗器械国家监管机构CDSCO批准上市。</p>
                  
</div>
            